THE API POWDER DIARIES

“The current scenario has uncovered some structural weaknesses during the EU’s medicines supply chain and a large dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that supply chain issues be tackled in an EU pharmaceutical strategy envisioned to get introduced by the top in the 12 mon